Matthew David Hall, MD

Andre Abitbol, M.D., is a radiation oncologist at Baptist Health Miami Cancer Institute. Dr. Abitbol received his medical degree from the Emory University School of Medicine in Atlanta, and completed a medicine internship at Grady Memorial Hospital, also in Atlanta. He completed a radiation oncology residency at the University of California Medical Center in San Francisco. He is board-certified in therapeutic radiology by the American Board of Radiology and serves as a clinical professor of radiation oncology at the University of Miami Miller School of Medicine. He is a prolific writer and researcher.

Rupesh Kotecha, M.D., is a radiation oncologist at Miami Cancer Institute. Dr. Kotecha has specialized training and experience in utilizing the latest in radiation therapy treatment techniques to treat cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiosurgery and stereotactic body radiation therapy. He has a specific interest and expertise in the use of stereotactic radiosurgery in the management of brain metastases to help improve both patient outcomes and quality of life.

Minesh Mehta, M.D., is a renowned expert in radiation oncology, proton therapy and cancer research and serves as deputy director and the John and Mary Lou Dasburg Endowed Chair in Radiation Oncology at Baptist Health Miami Cancer Institute, chief of Radiation Oncology at Baptist Health, and chair of the Department of Oncological Sciences at Florida International University Herbert Wertheim College of Medicine. Dr. Mehta received his medical degree with highest honors from the University of Zambia School of Medicine. He completed a residency at the University of Wisconsin, where he was later appointed chairman of the medical school’s Department of Human Oncology. As part of his leadership efforts, Dr. Mehta directed research studies, technology development and the expansion at the University of Wisconsin Cancer Center. He also directed its brain tumor program for more than 15 years, leading to his national leadership role in clinical trial research. Dr. Mehta has designed and led numerous national and international clinical studies, receiving National Institutes of Health and National Cancer Institute grants and winning honors for his research in brain and central nervous system tumors. He helped launch and was the medical director of the Maryland Proton Treatment Center in Baltimore, prior to joining Baptist Health. Dr. Mehta is board certified in radiation oncology by the American Board of Radiology and in neuro-oncology by the United Council for Neurologic Subspecialties. He has held national leadership positions in numerous organizations, including the American Board of Radiology, the FDA Radiological Devices Panel, the American Society for Radiation Oncology, the American Society of Clinical Oncology and the Society of Neuro-Oncology. An avid researcher, Dr. Mehta provides a multidisciplinary, innovative approach to individual care and helps all his patients understand their diagnosis, available treatment options and potential clinical trials